Evotec SE 20F 2023 Annual report | EVO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Abcam, accuracy, acid, acquiree, Affimed, ahead, anniversary, Antigen, AP, art, AstraZeneca, Basel, beauty, Bescheinigungsstelle, binary, blackout, bn, bond, boost, boosting, bore, bottom, Breda, breed, BSFZ, burnout, CAGR, Calcium, CAML, capitalist, ceiling, cGCP, cGLP, CGU, Chairwoman, character, Chimeric, Christian, CHRO, CISO, Clavystbio, claw, clearer, climate, Codex, Commerce, compliant, contributor, Corbion, Coty, CPO, CSRD, culminating, cyberattack, Dalbiez, Danone, dealer, Dearborn, degeneration, Deoxyribonucleic, depletion, deployment, dermatology, Diploma, disability, disconnected, distort, divisional, DoC, doubtful, DPF, du, dual, Duke, Duncan, Eastern, eat, EC, Edgewater, encompassing, Envirotainer, EPS, erroneously, escalation, Evelo, evenly, EVP, Exxon, ExxonMobil, Fitch, forgivable, formula, Forschungszulage, Founder, Frankreich, frequency, furniture, FVOCI, FVTOCI, FVTPL, FX, FYTOCI, FYTPL, graduate, Grand, ground, harbor, harmonizing, headquarter, headquartered, heightened, heightening, HGB, hoc, Hormuz, Immunoloy, improbable, incl, influx, Infosec, INSEE, insiginficant, interactor, interface, irremediably, ISG, ISO, Jan, Johann, Johnson, jubilee, KKR, KPCI, Leiden, lessee, lift, Lightstone, Linde, lump, MA, Macclesfield, macular, Marken, Mateo, McHale, Mediq, memory, Middle, middleware, MinStG, Misleading, morale, Muscular, NephTera, niche, Nordic, NUS, obsolescence, offline, oil, OMX, Oslo, outlook, output, Parliament, Patheon, paused, payer, payout, PCI, PhRMA, picture, Pluristyx, Portability, postpone, PPA, presumption, Proxygen, purple, Queen, ran, RDEC, recession, reconstruction, recurring, reinstated, remembered, repay, reprioritization, restoration, restore, resumed, ribonucleic, roughly, route, RSAo, sabbatical, Sandoz, Sex, Shenton, shoulder, shut, simplification, solvency, spirit, stewardship, Stockholm, Strait, streamline, Subcontracting, Surgery, survey, SVP, swelling, SWIFT, syndicated, TA, Taxonomy, ThermoFisher, ticker, tight, till, tn, transmembrane, tumor, turnover, unadjusted, unaffected, undrawn, Unforeseeable, unreliable, unstable, Urology, Wavin, Weatherden, welfare, Wesley, wet, Wheeler, WillisTowersWatson, Wojczewski, workflow, wother, Yale, Zealand

Removed: Aktiengesetz, amortisation, authorised, bid, biopharmaceutical, cent, Centre, closed, conducting, cycle, decade, determinable, dominant, Education, estimating, genetically, GPPP, guide, impede, indefinite, intention, legislative, marked, maximise, Merck, merger, persistent, postretirement, potent, preventing, proceed, realised, rejection, reliance, resigned, rest, satisfy, Scotland, shortage, staffed, steady, suggest, systematic, targeted, vaccine, Vifor, young

Evotec SE (EVO) 20-F2023 FY Annual report (foreign)

Content analysis